Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2002 Aug 1;113(2):91-8.
doi: 10.1016/s0002-9343(02)01169-5.

Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy

Mardge H Cohen  1 , Audrey L French, Lorie Benning, Andrea Kovacs, Kathryn Anastos, Mary Young, Howard Minkoff, Nancy A Hessol
Affiliations
Comparative Study

Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy

Mardge H Cohen et al. Am J Med. .

Abstract

Purpose: To examine changes in the causes of death and mortality in women with human immunodeficiency virus (HIV) infection in the era of combination antiretroviral therapy.

Methods: Among women with, or at risk of, HIV infection, who were enrolled in a national study from 1994 to 1995, we used an algorithm that classified cause of death as due to acquired immunodeficiency syndrome (AIDS) or non-AIDS causes based on data from death certificates and the CD4 count. Poisson regression models were used to estimate death rates and to determine the risk factors for AIDS and non-AIDS deaths.

Results: Of 2059 HIV-infected women and 569 who were at risk of HIV infection, 468 (18%) had died by April 2000 (451 HIV-infected and 17 not infected). Causes of death were available for 428 participants (414 HIV-infected and 14 not infected). Among HIV-infected women, deaths were classified as AIDS (n = 294), non-AIDS (n = 91), or indeterminate (n = 29). The non-AIDS causes included liver failure (n = 19), drug overdose (n = 16), non-AIDS malignancies (n = 12), cardiac disease (n = 10), and murder, suicide, or accident (n = 10). All-cause mortality declined an average of 26% per year (P = 0.03) and AIDS-related mortality declined by 39% per year (P = 0.01), whereas non-AIDS-related mortality remained stable (10% average annual decrease, P = 0.73). Factors that were independently associated with non-AIDS-related mortality included depression, history of injection drug use with hepatitis C infection, cigarette smoking, and age.

Conclusion: A substantial minority (20%) of deaths among women with HIV was due to causes other than AIDS. Our data suggest that to decrease mortality further among HIV-infected women, attention must be paid to treatable conditions, such as hepatitis C, depression, and drug and tobacco use.

PubMed Disclaimer

Figures

Figure
Figure
Change in Mortality in the Women’s Interagency HIV Study. HIV + indicates HIV infected; HIV– indicates not HIV infected. AIDS = acquired immunodeficiency syndrome; HIV = human immunodeficiency virus.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC; 2000.
    1. Palella FJ, Delaney KM, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;339:853–860. - PubMed
    1. McNaghten AD, Hanson DL, Jones JL, et al. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS. 1999;13:1687–1695. - PubMed
    1. Whitman S, Murphy J, Cohen M, Sherer R. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults and injection drug users, from 1995–1997. Arch Intern Med. 2000;160:365–369. - PubMed
    1. Anderson K, Mitchell J. Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival. Arch Intern Med. 2000;160:3114 –3120. - PubMed

Publication types

MeSH terms

Substances